In-Vitro Colorectal Cancer Screening Tests Market : Key Growth Factors and Industry Analysis | 2023

MaketStudyReport.com adds a New In-Vitro Colorectal Cancer Screening Tests Market Research Report for the period of 2016-2023 that shows the growth of the market is rising at a 5% CAGR to 2023.

In-Vitro Colorectal Cancer Screening Tests Market size will exceed USD 900 million by 2023.Demand for highly accurate and minimally invasive cancer screening tests is witnessed to increase R&D investments in colorectal cancer genetic screening tests. Introduction of favorable government initiatives is poised to rise the industry demand over the coming years. Colorectal cancer (CRC) yearly affects over one million women and men and causes more than half a million deaths. China in-vitro colorectal cancer screening tests market may generate over USD 35 million by 2023 due to colorectal cancer high death rates in the region over the past years.

UK and Germany in-vitro colorectal cancer screening tests market exhibits high growth due to increasing prevalence of disease. Germany in-vitro colorectal cancer screening tests market share is likely to grow at significant rate by 2023 with increasing government initiatives to improve cancer control with screening quality and healthcare funding.

Get sample Copy of this report:
https://www.marketstudyreport.com/request-a-sample/467720//?utm_source=OPR-PSR

Fecal occult blood (FOBT) testing is the most frequently used method. It is less expensive and has grownup existence in the healthcare industry in contrast to other tests. Methylated gene testing and transferrin assays are the new DNA screening and biomarker tests.

Demand for CRC DNA screening tests may increase at the highest CAGR by 2023, due to increasing R&D expenditure by major industry players in the advanced development. Immuno-FOB stool tests and transferrin assays has shown comparable accuracy owing to easy applicability and is forecast to observe rise in demand over the coming years. The use of non-invasive diagnostics for cancer screening test allows healthcare experts to conduct examinations relatively faster and with high accuracy. The entry of such technologically advanced genetic tests for cancer screening should positively affect the industry.

In 2016, nearly 60% - 70% of patients were suffering from CRC at mid or late stage when they were first-time diagnosed, leading to the high death rate. Recently, Cologuard (Exact Sciences) was approved by U.S. FDA and showed high CRC sensitivity (87%) and adenomas (82%). ColoVantage (Quest Diagnostics) is estimated to achieve an overall 70% sensitivity and 89% specificity. It has successfully detected cancer at all stages.

Promising geo-political scenario and government support in the developed regions of Europe and North America for catering the need of growing cases of colon and rectal cancer favors the future industry growth. Regional agencies have installed guidelines for the regular screening of colorectal cancer and risk levels of diagnosis associated with it.

Get Discount on this Report: https://www.marketstudyreport.com/check-for-discount/467720/

North America, led by U.S. in-vitro colorectal cancer screening tests market was valued at over USD 250 million in 2015. High presence of geriatric population and increasing prevalence of colorectal cancer may drive regional growth. UK in-vitro colorectal cancer screening tests market will the fastest growing in Europe by 2023 owing to favorable government policies and high disease prevalence rate.

Asia Pacific, driven by China and Japan, will be the fastest growing in-vitro colorectal cancer screening tests market, on account of increasing number of geriatric population and unhealthy lifestyles leading to cancer. Brazil and Mexico should grow at approximately similar rate with increasing healthcare expenditure.

Fecal occult blood test is the highest revenue generating test in 2015 due to increased use and easily applicable to large group of people at once. Immuno-FOB ELISA test market size may show significant gains at over 4.0% CAGR owing to accuracy offered by this test.

Global in-vitro colorectal cancer screening tests market is marked by strategic associations, mergers and acquisitions, and partnerships to expand product range. Major industry players are Alere, Abbott, Eiken Chemical, Siemens Healthcare and Beckman Coulter. Strict government policies challenge new players from entering the industry.

In-vitro colorectal cancer screening tests market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2012 to 2023, for the following segments:

In-Vitro Colorectal Cancer Screening Tests Market by Product:
o Fecal occult blood test:

Guaiac FOB stool test, Immuno-FOB agglutination test, Lateral flow immuno-FOB test, Immuno-FOB ELISA test

o Biomarker test:
Tumor M2-PK stool test, Transferrin assays, CRC DNA screening test, Methylated gene test, Panel DNA test

The above information has been provided on a regional and country basis for the following:

North America, U.S., Canada, Europe, Germany, UK, France, Italy, Russia, China, India, Japan, Latin America, Brazil, Mexico, MEA

For More Details On this Report: https://www.marketstudyreport.com/reports/in-vitro-colorectal-cancer-screening-tests-market/

Related Report:

United States Cancer Biomarkers Market Report 2017

In this report, the United States Cancer Biomarkers market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

https://www.marketstudyreport.com/reports/united-states-cancer-biomarkers-market-report-2017/?utm_source=RR-PSR

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
The Green Suite #4594,
Dover, DE 19901
United States
Phone: 1-201-355-0868
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Website: https://www.marketstudyreport.com
News: https://www.marketstudyreport.com/category/news-releases/

This release was published on openPR.